385 related articles for article (PubMed ID: 17049676)
21. Protection of BALB/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein.
Al-Mariri A
Vaccine; 2010 Feb; 28(7):1766-70. PubMed ID: 20036752
[TBL] [Abstract][Full Text] [Related]
22. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
[TBL] [Abstract][Full Text] [Related]
23. Selection of protective epitopes for Brucella melitensis by DNA vaccination.
Yang X; Hudson M; Walters N; Bargatze RF; Pascual DW
Infect Immun; 2005 Nov; 73(11):7297-303. PubMed ID: 16239526
[TBL] [Abstract][Full Text] [Related]
24. Pathogenicity and protective activity in pregnant goats of a Brucella melitensis Deltaomp25 deletion mutant.
Edmonds MD; Cloeckaert A; Hagius SD; Samartino LE; Fulton WT; Walker JV; Enright FM; Booth NJ; Elzer PH
Res Vet Sci; 2002 Jun; 72(3):235-9. PubMed ID: 12076120
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the virulence of a Brucella melitensis hemagglutinin gene in the caprine model.
Perry QL; Hagius SD; Walker JV; Elzer PH
Vaccine; 2010 Oct; 28 Suppl 5():F6-11. PubMed ID: 20362205
[TBL] [Abstract][Full Text] [Related]
26. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis.
Pasquevich KA; García Samartino C; Coria LM; Estein SM; Zwerdling A; Ibañez AE; Barrionuevo P; Oliveira FS; Carvalho NB; Borkowski J; Oliveira SC; Warzecha H; Giambartolomei GH; Cassataro J
J Immunol; 2010 May; 184(9):5200-12. PubMed ID: 20351187
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
[TBL] [Abstract][Full Text] [Related]
28. Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.
Al-Mariri A; Mahmoud NH; Hammoud R
Biologicals; 2012 Mar; 40(2):140-5. PubMed ID: 22296786
[TBL] [Abstract][Full Text] [Related]
29. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
Fan X; Gao Q; Fu R
Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
[TBL] [Abstract][Full Text] [Related]
30. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
Jacques I; Verger JM; Laroucau K; Grayon M; Vizcaino N; Peix A; Cortade F; Carreras F; Guilloteau LA
Vaccine; 2007 Jan; 25(5):794-805. PubMed ID: 17070627
[TBL] [Abstract][Full Text] [Related]
31. Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.
Izadjoo MJ; Bhattacharjee AK; Paranavitana CM; Hadfield TL; Hoover DL
Infect Immun; 2004 Jul; 72(7):4031-9. PubMed ID: 15213148
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen.
Yousefi S; Abbassi-Daloii T; Sekhavati MH; Tahmoorespur M
Microb Pathog; 2018 Feb; 115():50-56. PubMed ID: 29253594
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of Brucella ovis immunogenic proteins using two-dimensional electrophoresis and immunoblotting.
Teixeira-Gomes AP; Cloeckaert A; Bézard G; Bowden RA; Dubray G; Zygmunt MS
Electrophoresis; 1997 Aug; 18(8):1491-7. PubMed ID: 9298663
[TBL] [Abstract][Full Text] [Related]
34. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
[TBL] [Abstract][Full Text] [Related]
36. Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine.
Yang Y; Wang L; Yin J; Wang X; Cheng S; Lang X; Wang X; Qu H; Sun C; Wang J; Zhang R
Mol Immunol; 2011 Oct; 49(1-2):175-84. PubMed ID: 21943783
[TBL] [Abstract][Full Text] [Related]
37. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
[TBL] [Abstract][Full Text] [Related]
38. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
[TBL] [Abstract][Full Text] [Related]
39. Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species.
Vizcaíno N; Kittelberger R; Cloeckaert A; Marín CM; Fernández-Lago L
Infect Immun; 2001 Nov; 69(11):7020-8. PubMed ID: 11598077
[TBL] [Abstract][Full Text] [Related]
40. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.
Yang X; Walters N; Robison A; Trunkle T; Pascual DW
Vaccine; 2007 Mar; 25(12):2261-8. PubMed ID: 17239499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
